Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Oncology Research and Treatment|January 21, 2021
Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional European StudiesChristian Gessner, Karin Potthoff, Nikolaj FrostAmerican Journal of Respiratory Cell and Molecular Biology|September 10, 2003
Apoptosis and necrosis induced by cyclic mechanical stretching in alveolar type II cellsStefan Hammerschmidt, Hartmut Kuhn, Thomas Grasenack, et al.Oncology Reports|August 4, 2005
Release of bFGF following apoptosis and necrosis in NSCLC cells: effects on chemosensitivity to cisplatinHartmut Kuhn, Lucian Weser, Christian Gessner, et al.Biochimica Et Biophysica Acta|January 16, 2003
High in comparison with low tidal volume ventilation aggravates oxidative stress-induced lung injuryStefan Hammerschmidt, Torsten Sandvoss, Christian Gessner, et al.American Journal of Respiratory Cell and Molecular Biology|July 17, 2007
Stretch-induced alveolar type II cell apoptosis: role of endogenous bradykinin and PI3K-Akt signalingStefan Hammerschmidt, Hartmut Kuhn, Christian Gessner, et al.Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell linesHartmut Kuhn, Carmen Köpff, Jana Konrad, et al.Lung Cancer (Amsterdam, Netherlands)|January 24, 2004
Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patientsChristian Gessner, Hartmut Kuhn, Katja Toepfer, et al.Cancer Immunology, Immunotherapy : CII|August 31, 2002
Influence of adenoviral vector on expression of angiogenesis regulating factors in non-small cell lung cancer cell linesHartmut Kuhn, Alexander Riedel, Wolfram Eichler, et al.Deutsches Arzteblatt International|May 25, 2016
The Pharmacological Treatment of Chronic Obstructive Pulmonary DiseaseAdrian Gillissen, Peter Haidl, Martin Khlhäufl, et al.Thorax|February 14, 2015
Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority studyRoland Buhl, Christian Gessner, Wolfgang Schuermann, et al.Pageof 4